Metabolic Acidosis in a Woman With Stable HIV/AIDS

Article

An asymptomatic 42-year-old woman who has HIV/AIDS presents for aroutine check-up. She denies abdominal pain, nausea, vomiting, diarrhea,paresthesias, and muscle weakness.

An asymptomatic 42-year-old woman who has HIV/AIDS presents for aroutine check-up. She denies abdominal pain, nausea, vomiting, diarrhea,paresthesias, and muscle weakness.HISTORY
Her most recent CD4+ cell count was 298/μL, and her viral load wasless than 50 copies/mL. Her medications include didanosine, stavudine,nelfinavir, and trimethoprim-sulfamethoxazole (TMP-SMX) for Pneumocystisjiroveci (formerly Pneumocystis carinii) prophylaxis.PHYSICAL EXAMINATION
Vital signs are stable, and the results of a physical examination arenormal.LABORATORY RESULTS
Sodium level is 136 mEq/L; potassium, 3.9 mEq/L; chloride, 102 mEq/L;and bicarbonate, 13 mEq/L. Blood urea nitrogen level is 15 mg/dL; serumcreatinine, 1.1 mg/dL; and blood glucose, 85 mg/dL. Aspartate aminotransferaselevel is 32 U/L; alanine aminotransferase, 19 U/L.The anion gap is 21 mEq/L. To evaluate the anion gap elevation, thevenous lactate level is measured; the result is 79.1 mg/dL (8.78 mmol/L)(normal, 3 to 12 mg/dL [0.33 to 1.33 mmol/L]).Which of the following is the most likely cause of this patient'smetabolic acidosis? A. Type B lactic acidosis secondary to nucleoside reverse transcriptaseinhibitor (NRTI) therapy.
B. Infection caused by P jiroveci or other organisms.
C. Metabolic abnormalities related to hepatic dysfunction.
D. Renal insufficiency.

Recent Videos
Infectious disease specialist talks about COVID-19 vaccine development
COVID 19 impact on healthcare provider mental health
Physician mental health expert discusses impact of COVID-19 on health care workers
© 2024 MJH Life Sciences

All rights reserved.